Zydus Cadila gets tentative USFDA nod for Mirabegron ER tablets to treat overactive bladder Farhat Nasim2 April 2019 11:50 AM ISTThe company has received tentative approval from the United States Food and Drug Administration (USFDA) to market generic Mirabegron extended-release...
Dr Reddy's launches Tadalafil Tablets to treat erectile dysfunction Farhat Nasim28 March 2019 12:06 PM ISTDr Reddy's Tadalafil tablets are available in four strengths including 2.5 mg, 5 mg, 10 mg, and 20 mg, each in 30-count bottle size.New Delhi: Dr...
Lupin launches generic Levothyroxine Sodium tablets Farhat Nasim22 March 2019 11:30 AM ISTLupin's Levothyroxine Sodium tablet is the generic version of AbbVie Inc's Synthroid tablets, it added. New Delhi: Drug firm Lupin Friday said it has...
Dr Reddys launches B2B Customer Service Portal XCEED Garima19 March 2019 10:00 AM ISTDr Reddys launch of XCEED gives now instant access to an industry-leading portfolio which spans across a wide range of indications and complex...
Unichem Labs gets USFDA nod to market Allopurinol tablets Farhat Nasim15 March 2019 9:35 AM ISTAllopurinol tablets will be commercialised from company's Ghaziabad plant, Unichem Laboratories said.New Delhi: Drug firm Unichem Laboratories...
Laurus Labs gets USFDA nod to Hydroxychloroquine tablets for treating malaria Farhat Nasim12 March 2019 12:01 PM ISTHydroxychloroquine tablet is also used, usually with other medications, to treat certain auto-immune diseases (lupus, rheumatoid arthritis) when other...
Mylan launches Advair generic at 70 percent discount in US Farhat Nasim14 Feb 2019 9:15 AM ISTThe treatment, the first generic of Advair, is approved in three doses and will be priced between $93.71 and $153.14, the company said.U.S: Mylan NV...
Glenmark gets tentative USFDA nod to breast cancer injection Fulvestrant Farhat Nasim8 Feb 2019 11:40 AM ISTFulvestrant injection is a generic version of AstraZeneca Pharmaceuticals LP's Faslodex injection in the same strength, it added. The Faslodex...
Hetero launches generic Lapatinib under the brand name HERTAB in India Farhat Nasim12 Jan 2019 12:14 PM ISTHERTAB (Lapatinib) is an oral therapy indicated for the treatment of postmenopausal women with HER2-positive advanced breast cancer patients whose...
Lupin receives FDA approval for Clobazam Oral Suspension Farhat Nasim1 Jan 2019 10:00 AM ISTLupin's Clobazam Oral Suspension, 2.5 mg/mL is the generic version of Lundbeck Pharmaceuticals, LLC's Onfi Oral Suspension, 2.5 mg/mL. It is indicated...
Lupin launches generic Tetrabenazine Tablets Medical Dialogues Bureau22 Nov 2018 4:26 PM ISTMumbai: Pharma major Lupin announced the launch of Tetrabenazine Tablets, 12.5 mg and 25 mg having received an approval from the United States Food...
Mylan launches generic Angiomax injection Ruby Khatun Khatun22 Jun 2018 10:15 AM ISTHERTFORDSHIRE, England, and PITTSBURGH: Global pharmaceutical company Mylan N.V. announced the U.S. launch of Bivalirudin for Injection, 250 mg...
